Retatrutide is a new medication in the fight against obesity. This revolutionary drug, categorized as a dual GLP-1 and GIP receptor agonist, shows promising results in clinical trials. By stimulating these receptors, https://inessyex918572.mybuzzblog.com/16026719/tirzepatide-a-promising-new-treatment-for-obesity